These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8464020)
1. Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women. Messinis IE; MacTavish A; Templeton AA J Reprod Fertil; 1993 Jan; 97(1):271-5. PubMed ID: 8464020 [TBL] [Abstract][Full Text] [Related]
2. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle. Messinis IE; Lolis D; Zikopoulos K; Milingos S; Kollios G; Seferiadis K; Templeton AA Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the action of gonadotrophin surge-attenuating factor by gonadotrophin-releasing hormone. Messinis IE; Lolis D; Zikopoulos K; Tsahalina E; Seferiadis K; Templeton AA Hum Reprod; 1994 Aug; 9(8):1437-41. PubMed ID: 7989501 [TBL] [Abstract][Full Text] [Related]
4. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355 [TBL] [Abstract][Full Text] [Related]
5. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women. Messinis IE; Lolis D; Papadopoulos L; Tsahalina T; Papanikolaou N; Seferiadis K; Templeton AA Clin Endocrinol (Oxf); 1993 Jul; 39(1):45-50. PubMed ID: 8348707 [TBL] [Abstract][Full Text] [Related]
6. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle. Grimes EM; Thompson IE; Taymor ML Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349 [TBL] [Abstract][Full Text] [Related]
7. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy. Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880 [TBL] [Abstract][Full Text] [Related]
9. Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor (GnSAF) in vivo. Messinis IE; Hirsch P; Templeton AA Clin Endocrinol (Oxf); 1991 Nov; 35(5):403-7. PubMed ID: 1814653 [TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260 [TBL] [Abstract][Full Text] [Related]
11. Effect of an increase in FSH on the production of gonadotrophin-surge-attenuating factor in women. Messinis IE; Lolis D; Zikopoulos K; Tsahalina E; Seferiadis K; Templeton AA J Reprod Fertil; 1994 Aug; 101(3):689-95. PubMed ID: 7966027 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of gonadotrophin release and reserve in superovulated women by gonadotrophin surge attenuating factor (GnSAF). Messinis IE; Templeton A Clin Endocrinol (Oxf); 1991 Apr; 34(4):259-63. PubMed ID: 1908754 [TBL] [Abstract][Full Text] [Related]
14. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU). Gerris J; De Vits A; Joostens M; Van Royen E Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071 [TBL] [Abstract][Full Text] [Related]
15. Pituitary response to exogenous LHRH in superovulated women. Messinis IE; Templeton AA J Reprod Fertil; 1989 Nov; 87(2):633-9. PubMed ID: 2513393 [TBL] [Abstract][Full Text] [Related]
16. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM; Nestor JJ; Vickery BH Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [TBL] [Abstract][Full Text] [Related]
18. Circulating gonadotrophin surge-attenuating factor from superovulated women suppresses in vitro gonadotrophin-releasing hormone self-priming. Fowler PA; Cunningham P; Fraser M; MacGregor F; Byrne B; Pappas A; Messinis IE; Templeton A J Endocrinol; 1994 Oct; 143(1):45-54. PubMed ID: 7964321 [TBL] [Abstract][Full Text] [Related]
19. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Gelety TJ; Pearlstone AC; Surrey ES Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655 [TBL] [Abstract][Full Text] [Related]
20. Pituitary gonadotrophin secretion during the first weeks of pregnancy. Jeppsson S; Rannevik G; Thorell JI Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]